In a recent report, we evaluated SMYD3 somatic alterations and mRNA expression in CRCs and PCs by analyzing publicly available human cancer data from The Cancer Genome Atlas (TCGA) dataset, which contains records for many cancer types, including multi-omics and standardized clinical information. This evidence concerns the gene SMYD3 and cancer.